Safar Partners
Signal active
Investment Firm
Overview
Safar Partners is a seed- to growth-stage venture fund investing primarily in technology companies out of MIT, Harvard, and the University of Rochester. We invest in platform technologies in the cleantech and advanced materials, AI/IT and robotics, and life science/medical device areas.
Highlights
Founded
2019
Industry
Venture Capital
Employees
11-50
Investment
60
Lead Investment
13
Exits
2
Stages
Early Stage Venture, Seed, Late Stage Venture
Investor Type
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Safar Partners, established in 2019 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Food and Beverage, Food Processing, Nutrition, Alternative Protein, Financial Services, Venture Capital, Finance, Biotechnology, Automotive, Electronics. The organization boasts a portfolio of 61 investments, with an average round size of $70.1M and 2 successful exits. Their recent investments include Tender Food, Lowercarbon Capital, Rhapsody Venture Partners, Claridge Ventures, Lucy Therapeutics. The highest investment round they participated in was $639.8B. Among their most notable exits are Tender Food and Lowercarbon Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Safar Partners has made 60 investments. Their most recent investment was on Jun 17, 2024, when Tender Food raised $11.0M.
Safar Partners has made 21 diversity investments. Their most recent diversity investment was on May 28, 2024, when Lucy Therapeutics raised $12.5M.
investments
60
Diversity investments
21
Lead investments
13
Number of exits
2
Investments
60
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 06, 2024 | Zanskar | Information Technology | 30.0M |
| May 13, 2024 | Active Surfaces | Manufacturing | 5.6M |
| May 28, 2024 | Lucy Therapeutics | Biotechnology | 12.5M |
| Jun 17, 2024 | Tender Food | Food and Beverage | 11.0M |
Exits
2
Funding Timeline
Funding rounds
60
Investors
0
Funds
1
Funding Rounds
60
Safar Partners has raised 60 rounds. Their latest funding was raised on Jun 17, 2024 from a Series A - Tender Food round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 06, 2024 | Series B - Zanskar | - | 30.0M | - |
| May 13, 2024 | Pre Seed Round - Active Surfaces | - | 5.6M | - |
| May 28, 2024 | Venture Round - Lucy Therapeutics | - | 12.5M | - |
| Jun 17, 2024 | Series A - Tender Food | - | 11.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.